Cancer cells need oxygen to survive, as do most other life forms, but scientists had never tracked their search for oxygen in their early growth stages until now—a step toward a deeper understanding of one way cancer spreads ...
Aug 2, 2016
0
97
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals (UH) in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old ...
Jul 27, 2016
0
4
Adding a novel monoclonal antibody therapy to traditional chemotherapy increased median survival by nearly a year in patients with advanced sarcoma, a lethal soft-tissue cancer. Findings from a multicenter clinical trial ...
Jul 20, 2016
0
2
A new collaborative research program pairs oncologists who treat childhood and adult sarcomas with veterinarians who manage the same cancers in canine patients.
Jun 17, 2016
0
65
An existing cancer immunotherapy drug reduces tumor size in some types of rare connective tissue cancers, called sarcomas, report researchers at the University of Pittsburgh Cancer Institute (UPCI). Additional analyses of ...
Jun 6, 2016
0
3
Researchers at the Children's Cancer Institute (Instituto do Câncer Infantil, ICI), the Federal University of Rio Grande do Sul (UFRGS), the Cancer and Neurobiology Laboratory, and the Pediatric Oncology Service at the university ...
May 19, 2016
0
32
Molecular analysis of a tumor biopsy from a proto-oncogene 1 receptor tyrosine kinase positive (ROS1+) patient with acquired crizotinib resistance revealed a novel mutation in the v-kit Hardy Zuckerman 4 feline sarcoma viral ...
Apr 11, 2016
0
12
Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.
Mar 30, 2016
0
43
(HealthDay)—In a case report published online Feb. 28 in the Journal of Clinical Pharmacy and Therapeutics, researchers document non-HIV-associated Kaposi sarcoma in a male patient with myasthenia gravis and metastatic ...
Mar 17, 2016
0
0
(HealthDay)—Among patients undergoing surgery for benign gynecologic indications, the rate of occult uterine sarcoma is one in 1,124, according to a study published in the March issue of Obstetrics & Gynecology.
Feb 29, 2016
0
32
